2023 annual financial data
Pliant Therapeutics 2023 Net margin
Direct answer
Net margin was -10,211.14%.
Operating income was -184,145,000 USD and net income was -161,336,000 USD.
Operating cash flow was -116,361,000 USD.
Get free Pliant Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,580,000 USD
- Operating income
- -184,145,000 USD
- Net income
- -161,336,000 USD
- Operating cash flow
- -116,361,000 USD